SBIR/STTR Research Award
COUPLED ACOUSTICAL WAVE MICROPILLAR DETECTION OF DRUGS IN BLOOD POSTMORTEM
Award amount
$400,000Program and phase
SBIR · Phase IAward year
2023Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ADVANCED SILICON GROUP, INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- TFMUJ4XCD9K4
- Solicitation number
- PHS-2023-1
- Topic code
- 167
Research abstract
Drug Diagnostics Including Fentanyl Strips/CODE (Cause of Death Elucidated) in Drug Overdose: Rapid and portable cause of death detection technologies to improve drug overdose-related mortality counts
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need
- Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need
- SBIR Phase II: Improving silicon nanowire biosensors: throughput, repeatability, and quantifying measurement advantages
- Developing Silicon Nanowire Sensors to Measuring Host-Cell Proteins at a Biomanufacturing Line
- Measuring the Concentration of Host-cell Proteins in Biomanufacturing Using Silicon Nanowire Array Sensors
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- FY25. SBIR TOPIC 167 PHASE II: ULTRAPORTABLE LAB-ON-A-CHIP BIOSENSOR SYSTEM FOR RAPID POSTMORTEM TOXICOLOGY. PERIOD OF PERFORMANCE: 9/01/25-8/31/27
- FY23. SBIR TOPIC 167 PHASE I: ULTRAPORTABLE LAB-ON-A-CHIP BIOSENSOR SYSTEM FOR RAPID POSTMORTEM TOXICOLOGY. PERIOD OF PERFORMANCE: 9/27/23-9/26/24
- FY23. SBIR TOPIC 167 PHASE I: AN ARRAY-BASED MULTIPLEX IMMUNOASSAY FOR POSTMORTEM TOXICOLOGY SCREENING
Research funding history
7 SBIR/STTR records share this UEI (2017–2023). Reported award amounts total $3,236,494. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, National Science Foundation, Department of Commerce, Department of Health and Human Services